Table 5 Summary of main clinico-epidemiological studies carried out in dogs in continents other than Europe
From: Bartonella infections in cats and dogs including zoonotic aspects
Continent | Area or country | Bartonella spp. seroprevalence (%) | PCR / culture prevalence (%) | Confirmed Bartonella spp. and type | Reference |
|---|---|---|---|---|---|
Africa | East | nf | PCR: 0 | nf | [269] |
Central | nf | PCR: 2.3 | B. clarridgeiae, B. henselae | [27] | |
North | 19.5–47.4 | PCR: 0.85–37.1 | B. clarridgeiae, B. elizabethae, B. henselae, B. rochalimae, B. vinsonii berkhoffii | ||
South | 14 | PCR: 0–9.0; Culture: 0 | B. henselae | ||
West | nf | PCR: 0 | nf | [275] | |
Asia | Middle East | 6.6–47.4 | Culture and PCR: 9.2–37.1 | “Candidatus Bartonella merieuxii”, B. vinsonii berkhoffii (type III in one study) | |
South Korea | nf | PCR: 0–29.6 | B. clarridgeiae, B. henselae | ||
Sri Lanka | 5.1 | PCR: 3.38 | Bartonella strain HMD | [281] | |
Thailand | 38 | PCR: 1.8; Culture and PCR: 0.3–31.3 | B. clarridgeiae, B. elizabethae, B. grahamii, B. quintana, B. taylorii, B. vinsonii arupensis | ||
Vietnam | 0 | PCR: 0 | nf | [281] | |
Australia | New South Wales and Northern Territory | 0 | Culture and PCR: 0 | nf | [285] |
North America | Centre | 0–20 | nf | nf | |
East | 0–49 | PCR: 9.2; Culture: 52.5 | B. bovis, B. henselae, B. koehlerae, B. vinsonii berkhoffiii, B. volans-like | ||
West | 0–29 | PCR: 0–1.7; Culture: 2.2 | B. clarridgeiae-like, B. vinsonii berkhoffii | ||
South America | Argentina | nf | PCR: 3 | B. clarridgeiae | [260] |
Brazil | 1.5–24.8 | PCR and culture: 1 | B. henselae, B. vinsonii berkhoffii | ||
Chile | nf | PCR: 4.3 | B. henselae, B. vinsonii berkhoffii | [290] | |
Colombia | 10.1 | PCR: 0.77 | B. rochalimae, B. vinsonii berkhoffii | [281] | |
Galapagos Islands | nf | PCR: 13.6 | B. clarridgeiae, B. elizabethae, B. henselae | [267] | |
Peru | 40–62 | PCR: 10 | B. rochalimae, B. vinsonii berkhoffii type III | [291] |